Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

Pancreatitis

Free Subscription Articles published in J Surg Res Retrieve available abstracts of 30 articles: HTML format

Single Articles

October 2023
1. OLECKI EJ, Perez Holguin RA, Mayhew MM, Wong WG, et al
   Disparities in Surgical Treatment of Resectable Pancreatic Adenocarcinoma at Minority Serving Hospitals.
   J Surg Res. 2023;294:160-168.
   PubMed     Abstract available
   
   
   September 2023
2. LI KW, Chen WS, Wang K, Yang C, et al
   Open or Not Open the Retroperitoneum: A Pandora's Box for Blunt High-Grade Pancreatic Trauma?
   J Surg Res. 2023;293:79-88.
   PubMed     Abstract available
   
   
   July 2023
3. PAPAGEORGE MV, de Geus SWL, Woods AP, Ng SC, et al
   The Evaluation of Gallstone Disease in the Year Before Pancreatic Cancer Diagnosis.
   J Surg Res. 2023;291:282-288.
   PubMed     Abstract available
   
   
   April 2023
4. CHAWLA M, Villarreal ME, Waterman BL, Di Tosto G, et al
   Utilization of Palliative and Hospice Care Among Pancreatic Cancer Patients at an Academic Center.
   J Surg Res. 2023;289:22-26.
   PubMed     Abstract available
   
   
   
5. BALAZ P, Gurlich R, Havluj L, Girsa D, et al
   Segmental Versus Partial Portomesenteric Resection in Pancreatectomy for Pancreatic Cancer.
   J Surg Res. 2023;288:233-239.
   PubMed     Abstract available
   
   
   March 2023
6. ALTERIO RE, Meier J, Radi I, Bhat A, et al
   Defining the Price Tag of Complications Following Pancreatic Surgery: A US National Perspective.
   J Surg Res. 2023;288:87-98.
   PubMed     Abstract available
   
   
   January 2023
7. BLUNCK CK, Vickers SM, Wang TN, Dudeja V, et al
   Adjusting Drain Fluid Amylase for Drain Volume Does Not Improve Pancreatic Fistula Prediction.
   J Surg Res. 2023;284:312-317.
   PubMed     Abstract available
   
   
   
8. WANG M, Tong K, Chen Z, Wen Z, et al
   Mechanisms of 15-Epi-LXA4-Mediated HO-1 in Cytoprotection Following Inflammatory Injury.
   J Surg Res. 2023;281:245-255.
   PubMed     Abstract available
   
   
   December 2022
9. KHACHFE HH, Hammad AY, AlMasri S, deSilva A, et al
   Obesity is Associated With Increased Risk for Adverse Postoperative Outcomes After Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma.
   J Surg Res. 2022;284:164-172.
   PubMed     Abstract available
   
   
   
10. FANG HA, Irfan A, Vickers SM, Gbolahan O, et al
    Are Lymph Node Metastases Associated With Survival in Black Patients With Pancreatic Cancer?
    J Surg Res. 2022;284:143-150.
    PubMed     Abstract available
    
    
    
11. CHALFANT H, Bonds M, Scott K, Condacse A, et al
    Innovative Imaging Techniques Used to Evaluate Borderline-Resectable Pancreatic Adenocarcinoma.
    J Surg Res. 2022;284:42-53.
    PubMed     Abstract available
    
    
    November 2022
12. CAIAZZA F, Conroy PC, Ivry SL, York T, et al
    Accurate Identification of Mucinous Pancreatic Cystic Lesions Using Small-Volume Analytes.
    J Surg Res. 2022 Nov 8. pii: S0022-4804(22)00519.
    PubMed     Abstract available
    
    
    September 2022
13. BARRAK D, Villano AM, Moslim MA, Hopkins SE, et al
    Total Neoadjuvant Treatment for Pancreatic Ductal Adenocarcinoma Is Associated With Limited Lymph Node Yield but Improved Ratio.
    J Surg Res. 2022;280:543-550.
    PubMed     Abstract available
    
    
    August 2022
14. ARNOLD P, Belchos J, Meagher A, Robbins C, et al
    Postoperative Pancreatic Fistula Following Traumatic Splenectomy: A Morbid and Costly Complication.
    J Surg Res. 2022;280:35-43.
    PubMed     Abstract available
    
    
    
15. NAFFOUJE SA, Allenson K, Hodul P, Malafa M, et al
    Prophylactic Perioperative Antibiotics in Open Pancreaticoduodenectomy: When Less Is More and When It Is Not. A National Surgical Quality Improvement Program Propensity-Matched Analysis.
    J Surg Res. 2022;279:722-732.
    PubMed     Abstract available
    
    
    April 2022
16. L'HUILLIER JC, Kalbfell EL, Lemahieu MR, Stafford NT, et al
    Severe Pancreatitis Multidisciplinary Working Group: Exploratory Analysis to Optimize Care and Cost.
    J Surg Res. 2022;277:244-253.
    PubMed     Abstract available
    
    
    
17. HUE JJ, Sugumar K, Elshami M, Rothermel LD, et al
    Time to Neoadjuvant Chemotherapy Initiation is not Associated With Survival in Pancreatic Cancer.
    J Surg Res. 2022;276:369-378.
    PubMed     Abstract available
    
    
    February 2022
18. SIEGEL JB, Mukherjee R, Lancaster WP, Morgan KA, et al
    Distal Pancreatectomy for Pancreatitis in the Modern Era.
    J Surg Res. 2022;275:29-34.
    PubMed     Abstract available
    
    
    October 2021
19. AYALA CI, Li AY, Lu A, Wilson A, et al
    More Than an ERAS Pathway is Needed to Meet Target Length of Stay After Pancreaticoduodenectomy.
    J Surg Res. 2021;270:195-202.
    PubMed     Abstract available
    
    
    September 2021
20. TORPHY RJ, Friedman C, Halpern AL, Ahrendt SA, et al
    Implementation of Minimally Invasive Pancreaticoduodenectomy at Low and High-volume Centers.
    J Surg Res. 2021;268:720-728.
    PubMed     Abstract available
    
    
    April 2021
21. GARCIA DI, Hurst KE, Bradshaw A, Janakiraman H, et al
    High-Fat Diet Drives an Aggressive Pancreatic Cancer Phenotype.
    J Surg Res. 2021;264:163-172.
    PubMed     Abstract available
    
    
    January 2021
22. ODAGIRI T, Asano Y, Kagiya T, Matsusaki M, et al
    The Cell Line-Dependent Diversity in Initial Morphological Dynamics of Pancreatic Cancer Cell Peritoneal Metastasis Visualized by an Artificial Human Peritoneal Model.
    J Surg Res. 2021;261:351-360.
    PubMed     Abstract available
    
    
    
23. YOON BH, Ang SM, Alabd A, Furlong K, et al
    Pancreatic Cancer-Associated Diabetes is Clinically Distinguishable From Conventional Diabetes.
    J Surg Res. 2021;261:215-225.
    PubMed     Abstract available
    
    
    
24. KOLIAKOS NN, Renieris G, Sotiropoulos D, Pavlou K, et al
    Immunomodulation Through Beta-D-glucan in Chemically-induced Necrotizing Pancreatitis.
    J Surg Res. 2021;261:74-84.
    PubMed     Abstract available
    
    
    December 2020
25. PINEDA-SOLIS K, Burchard PR, Ruffolo LI, Schoeniger LO, et al
    Early Prediction of Length of Stay After Pancreaticoduodenectomy.
    J Surg Res. 2020 Dec 22. pii: S0022-4804(20)30807.
    PubMed     Abstract available
    
    
    
26. CHENG Y, Wu D, Wang L, Liu H, et al
    Cystic Pancreatic Neuroendocrine Tumors Represent a Distinct Clinical Entity with Less Aggressive Biological Behaviors.
    J Surg Res. 2020;260:134-140.
    PubMed     Abstract available
    
    
    
27. ALHATEM A, Quinn PL, Xia W, Chokshi RJ, et al
    Pancreatic Carcinosarcoma Clinical Outcome Analysis of the National Cancer Institute Database.
    J Surg Res. 2020;259:62-70.
    PubMed     Abstract available
    
    
    
28. PAIELLA S, Casetti L, Ewald J, Marchese U, et al
    Laser Treatment (imILT) of Pancreatic Cancer: Safety and Feasibility Results From Two Phase 2a Studies.
    J Surg Res. 2020;259:1-7.
    PubMed     Abstract available
    
    
    October 2020
29. PERRIN J, Ratnayake B, Wells C, Windsor JA, et al
    Epidural Versus Transabdominal Wall Catheters: A Comparative Study of Outcomes After Pancreatic Resection.
    J Surg Res. 2020 Oct 15. pii: S0022-4804(20)30667.
    PubMed     Abstract available
    
    
    
30. WINER LK, Cortez AR, Ahmad SA, Wima K, et al
    Evaluating the Impact of ESPAC-1 on Shifting the Paradigm of Pancreatic Cancer Treatment.
    J Surg Res. 2020 Oct 12. pii: S0022-4804(20)30671.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pancreatitis is free of charge.